Pinnacle Clinical Research, LLC

San Antonio, Texas 78229

2 studies enrolling now · 6 studies all time

What they study most

Cardiovascular Diseases, Compensated Liver Cirrhosis, Diabetes Mellitus, Type 2, Healthy, Hepatic Impairment, Hypertension, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis (MASH), Nonalcoholic Steatohepatitis, Steatohepatitis

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis — Recruiting now
• A Study to Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH — Completed
• Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function — Completed
• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4 — Stopped early